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Introduction: Primary Biliary Cirrhosis is a chronic progressive cholestatic disorder o f  
unknown etiology, pathogenesis, characterized histologically by autoimmune inflammation o f  the 
biliary ducts interlobular septal and intrahepatic granulomatous destructive, associated with the 
presence o f  antimitochondrial antibody, cholestatic jaundice and pruritus. Primary biliary cirrhosis 
is ~ 0,6-2% o f  deaths from hepatic cirrhosis. Caution is required for diagnosis in women o f  average 
age with cutaneous pruritus, jaundice, steatorrhea and skin pigmentation.
Purpose and objectives: The study o f hepatic and extrahepatic manifestations in primary 
biliary cirrhosis.
Materials and methods: Retrospective study o f  40 patients hospitalized in Hepatology 
section o f  Republican Clinical Hospital was performed. 37 women (92.5%) and 3 men (7.5%) with 
a mean age o f  47.7 years were included.
Results: Typical hepatic manifestations o f  primary biliary cirrhosis were: hepatomegaly (34 
patients; 85%), splenomegaly (21; 52.5%), skin jaundice (20; 50%), pruritus cutaneous (22; 55%) 
and asthenia (30; 75%). As extrahepatic manifestations were detected: osteoporosis (4 patients; 
10%), arthralgia (7; 17.5%) and pneumosclerosis (7; 17.5%). Conditions associated with primary 
biliary cirrhosis were: thyroid diseases (6 patients; 15%), rheumatoid polyarthritis (4; 10%) and 
diabetes mellitus (5; 12.5 %). Biological markers associated with clinical features were: 
antimitochondrial antibodies (32 patients; 80%), antinuclear antibodies (8; 20%), rheumatoid factor 
(6; 15%) and cryoglobulins (3; 7.5%).
Conclusion: In primary biliary cirrhosis classic symptoms (cutaneous pruritus, jaundice, 
hepatomegaly, splenomegaly and asthenia) may be associated with extrahepatic manifestations as: 
osteoporosis, arthralgia, pneumosclerosis, diabetes, rheumatoid arthritis and thyroid affectation.
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Introduction: The diagnosis and treatment o f  sleep disorders require special attention 
because they can have serious psycho-behavioral, cardiovascular, metabolic consequences and can 
influence the intellectual performance and social relationships. The central type o f  sleep apnea 
syndrome represents a set o f  signs and symptoms caused by stops (apnea) or slow downs 
(hypopnea) o f  respiratory flow during sleep caused by central nervous system disorders (respiratory 
center) with a frequency o f  more than 5 episodes per hour and lasting more than 10 seconds. 
Considering the consequences it has on the body, the SAS diagnosed patient requires a 
multidisciplinary approach: ENT, pneumology, neurology, cardiology, and psychiatry.
Materials and methods: Relevant articles on the topic for the period from 2000 to 2014 were 
analyzed, using PubMed data base and other sources.
Results: The central type o f  sleep apnea syndrome is found more often in patients with heart 
failure, o f which 20-30% at the patients with systolic heart failure. 10% o f all patients with sleep apnea 
syndrome, registered at the study o f  sleep laboratories, present central type o f  apnea. (PSG) is the most 
informative and base method in diagnosis o f  sleep apnea, fact confirmed by practice. The best method 
o f treatment has proved CPAP-therapy (continuous positive airway pressure). In the modern treatment 
is used auto-CPAP-therapy witch allows automatic recording and dosing o f the inspired air flow.
Conclusion: We determined the following aspects:
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